Trial to Assess Chelation Therapy (TACT). Principal Investigator: Gervasio A. Lamas, MD Mount Sinai Medical Center – Miami Heart Institute Miami Beach FL. TACT Design. 5-year randomized, double-blind, placebo-controlled; 2X2 factorial trial;
Principal Investigator: Gervasio A. Lamas, MD
Mount Sinai Medical Center – Miami Heart Institute
Miami Beach FL
Two substudies will be conducted whose specific aims are as follows:
This requires PI involvement, especially the decision that the CAD corresponds to an imaged scar. Remember that the CCC is always happy to help.
With these assumptions, 2,372 patients will
Investigator training module completed
These supplements, produced by OleoMed S.A., Madrid, Spain, are administered in an olive oil based gel capsule.
Data collected by structured interview in 1000 randomly selected patients